INS and Alzheimer disease: Some researchers and scientists have begun to recognize AD as “diabetes of the brain”, or T3cDM, as it has been discovered that decreasing amounts of insulin in significant neuropathways causes detrimental effects on cognitive performance and the prevention of synaptic losses [90,91,92,93,94].